Eli Lilly Settles Dispute Over Antibody Research Patents
In a sealed settlement agreement for recombinant protein technologies, drug maker Eli Lilly has ended infringement litigation against a European rival....To view the full article, register now.
Already a subscriber? Click here to view full article